Unchanged Prevalence of Preeclampsia After Implementation of Prophylactic Aspirin for All Pregnant Women With Preexisting Diabetes: A Prospective Cohort Study.

Nicoline Callesen DoMarianne VestgaardBjörg Ásbjörnsdóttir Sidse Kjærhus NørgaardLise Lotte T AndersenDorte M JensenLene RingholmPeter DammElisabeth Reinhardt Mathiesen

Published in: Diabetes care (2021)

Implementation of prophylactic aspirin for all pregnant women with diabetes did not reduce the prevalence of preeclampsia compared with the previous risk-based prophylaxis in this cohort study.

Keyphrases

type diabetes
low dose
cardiovascular disease
primary care
early onset
risk factors
healthcare
glycemic control
cardiovascular events
pregnant women
quality improvement
antiplatelet therapy
pregnancy outcomes
coronary artery disease
percutaneous coronary intervention
weight loss
insulin resistance